Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01UBA
|
|||
Drug Name |
PMID25656651-Compound-30a
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
PIRAMAL HEALTHCARE LIMITED SIVAKUMAR, Meenakshi JOSHI, Kalpana Sanjay AWARE, Valmik Sopan SARDE, Ankush Gangaram BAGUL, Sandeep Mukunda MANOHAR, Sonal Mohan
|
|||
Structure |
Download2D MOL |
|||
Formula |
C13H14N2O3
|
|||
Canonical SMILES |
CCCC1=NOC(=N1)C=CC2=CC(=C(C=C2)O)O
|
|||
InChI |
1S/C13H14N2O3/c1-2-3-12-14-13(18-15-12)7-5-9-4-6-10(16)11(17)8-9/h4-8,16-17H,2-3H2,1H3/b7-5+
|
|||
InChIKey |
MAWOOXDYMFRJNN-FNORWQNLSA-N
|
|||
CAS Number |
CAS 1332498-21-1
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fusion protein Bcr-Abl (Bcr-Abl) | Target Info | Inhibitor | [1] |
Target's Patent Info | Fusion protein Bcr-Abl (Bcr-Abl) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.